News					
						
                                         
                                    
                			Investment in needle free vaccines could significantly reduce infectious disease
Positive results announced by Micron Biomedical earlier this week stated that a measles and rubella vaccine patch has completed a Phase 1/2 clinical trial. These are ...
					 
                                                        
    					










